Rani Therapeutics
RANI
34 hedge funds and large institutions have $6.96M invested in Rani Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.
0.15% less ownership
Funds ownership: 12.72% → 12.57% (-0.15%)
3% less funds holding
Funds holding: 35 → 34 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
47% less capital invested
Capital invested by funds: $13.3M → $6.96M (-$6.29M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$249K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$197K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$133K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.8K |
| 5 |
AWM
Activest Wealth Management
Aventure,
Florida
|
+$37.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$334K |
| 2 |
HF
HRT Financial
New York
|
-$170K |
| 3 |
Renaissance Technologies
New York
|
-$142K |
| 4 |
ASGS
Alpha Square Group S
New York
|
-$55.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$36.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $9.65K | -$7.97K | -2,086 | -32% |
|
|
AF
27
Allworth Financial
Folsom,
California
| $6.78K | -$11 | -3 | -0.1% |
|
|
IWP
28
IAG Wealth Partners
Waukesha,
Wisconsin
| $2.19K | – | – | – |
|
29
Simplex Trading
Chicago,
Illinois
| $2K | -$1.18K | -308 | -20% |
|
30
Morgan Stanley
New York
| $1.96K | -$3.86K | -1,010 | -53% |
|
31
RhumbLine Advisers
Boston,
Massachusetts
| $678 | – | – | – |
|
32
Wells Fargo
San Francisco,
California
| $204 | +$65 | +17 | +22% |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| $7 | +$11 | +3 | New |
|
|
HF
34
HRT Financial
New York
| – | -$170K | -41,342 | Closed |
|
|
35
Citadel Advisors
Miami,
Florida
| – | -$36.9K | -8,955 | Closed |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | -$29K | -7,048 | Closed |
|
|
FCA
37
FinTrust Capital Advisors
Greenville,
South Carolina
| – | -$443 | -75 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$168 | -44 | -51% |
|
RANI Hedge Fund Activity: Q3 2023 in Review
34 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rani Therapeutics (RANI) for Q3 2023, worth a combined $6.96M — down 47% from $13.3M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RANI and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 6 added.
The largest buyer was Stifel Financial, adding an estimated $249K. The largest seller was Millennium Management, cutting an estimated $334K.
- 34 institutional investors held Rani Therapeutics (RANI) as of Q3 2023, down from 35 in Q2 2023.
- Funds reported $6.96M of Rani Therapeutics stock for Q3 2023, down 47% quarter-over-quarter.
- 3 funds opened new Rani Therapeutics positions in Q3 2023 and 4 closed out, a net change of -1 holder.
- The largest Rani Therapeutics buyer in Q3 2023 was Stifel Financial, an estimated $249K added.
- The largest Rani Therapeutics seller in Q3 2023 was Millennium Management, an estimated $334K sold.
Based on aggregated 13F filings for Q3 2023.